Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ATP13A2 Antikörper (AA 1001-1080) (Alexa Fluor 555)

ATP13A2 Reaktivität: Ratte IF (cc), IF (p) Wirt: Kaninchen Polyclonal Alexa Fluor 555
Produktnummer ABIN1392869
  • Target Alle ATP13A2 Antikörper anzeigen
    ATP13A2 (ATPase Type 13A2 (ATP13A2))
    Bindungsspezifität
    • 14
    • 8
    • 7
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1001-1080
    Reaktivität
    • 25
    • 17
    • 4
    • 1
    Ratte
    Wirt
    • 37
    • 3
    Kaninchen
    Klonalität
    • 38
    • 2
    Polyklonal
    Konjugat
    • 16
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser ATP13A2 Antikörper ist konjugiert mit Alexa Fluor 555
    Applikation
    • 20
    • 19
    • 12
    • 12
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
    Kreuzreaktivität
    Ratte
    Homologie
    Human,Mouse,Cow,Pig,Horse,Rabbit
    Aufreinigung
    Purified by Protein A.
    Immunogen
    KLH conjugated synthetic peptide derived from human ATP13A2
    Isotyp
    IgG
    Top Product
    Discover our top product ATP13A2 Primärantikörper
  • Applikationshinweise
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Haltbarkeit
    12 months
  • Target
    ATP13A2 (ATPase Type 13A2 (ATP13A2))
    Andere Bezeichnung
    PARK9/ATP13A2 (ATP13A2 Produkte)
    Synonyme
    ATP13A2 antikoerper, 1110012E06Rik antikoerper, AA589443 antikoerper, RGD1307977 antikoerper, im:7147302 antikoerper, zgc:136762 antikoerper, CLN12 antikoerper, HSA9947 antikoerper, KRPPD antikoerper, PARK9 antikoerper, ATPase 13A2 antikoerper, ATPase type 13A2 antikoerper, probable cation-transporting ATPase 13A2 antikoerper, ATP13A2 antikoerper, Atp13a2 antikoerper, atp13a2 antikoerper, PTRG_01071 antikoerper, MCYG_01937 antikoerper, LOC100439053 antikoerper
    Hintergrund

    Synonyms: AT132_HUMAN, Atp13a2, ATPase type 13A2, CLN12, HSA9947, KRPPD, PARK9, Probable cation transporting ATPase 13A2, Probable cation-transporting ATPase 13A2, Putative ATPase, RP1-37C10.4.

    Background: ATP13A2 is a 1,180 amino acid multi-pass membrane protein that belongs to the P5 subfamily of ATPases which play an important role in the transportation of inorganic cations. Expressed as multiple alternative spliced isoforms, ATP13A2 functions to catalyze the conversion of ATP to ADP and a free phosphate, thereby participating in the active transport of ions across cellular membranes. Defects in the gene encoding ATP13A2 are the cause of Kufor-Rakeb syndrome (KRS), a rare hereditary type of Parkinson?s disease that exhibits juvenile onset and is characterized by neurodegeneration and dementia. The ATP13A2 gene maps to human chromosome 1, which spans 260 million base pairs, contains over 3,000 genes and comprises nearly 8 % of the human genome.

    Pathways
    Ribonucleoside Biosynthetic Process
Sie sind hier:
Kundenservice